{"data":[{"accessionNo":"0001628280-26-015264","issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals","ticker":"ARWR","personName":"James Hamilton","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":641870.05,"unitsOutstanding":140032190,"approxSaleDate":"2026-03-05","exchange":"NASDAQ","filedAt":"2026-03-05"},{"accessionNo":"0001628280-26-000759","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"James Hamilton","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":40164,"aggregateMarketValue":2534478.03,"unitsOutstanding":135809558,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05"},{"accessionNo":"0001628280-26-000582","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"James Hamilton","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":39728,"aggregateMarketValue":2506627.22,"unitsOutstanding":135809558,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05"},{"accessionNo":"0001628280-26-000575","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Patrick O'Brien","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":49493,"aggregateMarketValue":3123171.63,"unitsOutstanding":135809558,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05"},{"accessionNo":"0001628280-26-000119","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Christopher Anzalone","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":13187,"aggregateMarketValue":871667.85,"unitsOutstanding":135809558,"approxSaleDate":"2026-01-02","exchange":"NASDAQ","filedAt":"2026-01-02"},{"accessionNo":"0001628280-25-058998","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Christopher Anzalone","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":51726,"aggregateMarketValue":3575575.42,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-29","exchange":"NASDAQ","filedAt":"2025-12-29"},{"accessionNo":"0001628280-25-058965","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Mauro Ferrari","relationship":"Director","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":7530,"aggregateMarketValue":527070.05,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-26","exchange":"NASDAQ","filedAt":"2025-12-29"},{"accessionNo":"0001628280-25-058500","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Christopher Anzalone","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":12586,"aggregateMarketValue":861319.3,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-22","exchange":"NASDAQ","filedAt":"2025-12-22"},{"accessionNo":"0001628280-25-058256","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Christopher Anzalone","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":13445,"aggregateMarketValue":909632.44,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-19","exchange":"NASDAQ","filedAt":"2025-12-19"},{"accessionNo":"0001628280-25-058254","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"William Waddill","relationship":"Director","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":8367,"aggregateMarketValue":566000.65,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-19","exchange":"NASDAQ","filedAt":"2025-12-19"},{"accessionNo":"0001628280-25-058251","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Adeoye Olukotun","relationship":"Director","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":676588.82,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-19","exchange":"NASDAQ","filedAt":"2025-12-19"},{"accessionNo":"0001628280-25-058250","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Victoria Vakiener","relationship":"Director","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":10040,"aggregateMarketValue":679463.51,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-19","exchange":"NASDAQ","filedAt":"2025-12-19"},{"accessionNo":"0001628280-25-057709","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Christopher Anzalone","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":85000,"aggregateMarketValue":5443252.88,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-17","exchange":"NASDAQ","filedAt":"2025-12-17"},{"accessionNo":"0001628280-25-057417","issuerCik":"0000879407","issuerName":"Arrowhead","ticker":"ARWR","personName":"Christopher Anzalone","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":54298,"aggregateMarketValue":3398141.91,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-16","exchange":"NASDAQ","filedAt":"2025-12-16"},{"accessionNo":"0001628280-25-057066","issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals","ticker":"ARWR","personName":"Christopher Anzalone","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":130000,"aggregateMarketValue":8950579.9,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-15","exchange":"NASDAQ","filedAt":"2025-12-15"},{"accessionNo":"0001628280-25-055570","issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals","ticker":"ARWR","personName":"Michael Perry","relationship":"Director","securityClass":"common","broker":"Merrill Lynch","unitsToSell":16250,"aggregateMarketValue":991129.29,"unitsOutstanding":135809558,"approxSaleDate":"2025-12-05","exchange":"NASDAQ","filedAt":"2025-12-05"},{"accessionNo":"0001628280-25-054254","issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals","ticker":"ARWR","personName":"Mauro Ferrari","relationship":"Director","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":8750,"aggregateMarketValue":493062.5,"unitsOutstanding":135809558,"approxSaleDate":"2025-11-28","exchange":"NASDAQ","filedAt":"2025-11-28"},{"accessionNo":"0001628280-25-043402","issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals","ticker":"ARWR","personName":"James Hamilton","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":20000,"aggregateMarketValue":700014.67,"unitsOutstanding":138257550,"approxSaleDate":"2025-10-01","exchange":"NASDAQ","filedAt":"2025-10-01"}],"updatedAt":"2026-10-14T09:13:20.387Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}